首页 | 本学科首页   官方微博 | 高级检索  
     


A novel alteration in metaxin 1, F202L,is associated with N370S in Gaucher disease
Authors:Mary?E.?LaMarca,Mona?Goldstein,Nahid?Tayebi,Mauricio?Arcos-Burgos,Brian?M.?Martin,Ellen?Sidransky  mailto:sidranse@irp.nimh.nih.gov"   title="  sidranse@irp.nimh.nih.gov"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author
Affiliation:(1) Medical Genetics Branch, National Human Genome Research Institute, Bethesda, MD 20892-4405, USA;(2) Section on Molecular Neurogenetics, National Institute of Mental Health, 49 Convent Drive MSC4405, 49/B1EE16, Bethesda, MD 20892-4405, USA;(3) Laboratory of Neurotoxicology, National Institute of Mental Health, Bethesda, MD 20892-4405, USA
Abstract:
The gene for glucocerebrosidase (GBA), the enzyme deficient in Gaucher disease, is located in a gene-rich region on 1q21. Metaxin 1(MTX1) is a convergently transcribed gene contiguous to the 3prime end of the GBA pseudogene. A single nucleotide alteration in MTX1, 628TrarrC, resulting in the amino acid change F202L, was identified in patients with Gaucher disease in association with the common N370S mutation in GBA. The polymorphism was also present on 4.6% of 152 control alleles, but could have functional consequences that have a modifying role in Gaucher disease.
Keywords:Gaucher disease  Genotype/phenotype correlation  Glucocerebrosidase  Haplotype  Metaxin  Polymorphism
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号